Tonix Pharmaceuticals Holding Corp. (TNXP)

TNXP Analyst Ratings

TNXP's stock price has decreased by -99.03% in the past year and price targets may not have had time to catch up.

• Total Analysts: 2
• Consensus Rating: Strong Buy
• Price Target: $176.00
• Upside: +32,187.65%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Kolbert Dawson James	Dawson James	Strong Buy Initiates $96	Strong Buy	Initiates	$96	+17,511.45%	Feb 28, 2024
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $576 → $256	Strong Buy	Maintains	$576 → $256	+46,863.86%	Aug 1, 2023
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $208 → $576	Strong Buy	Maintains	$208 → $576	+105,568.68%	Jun 2, 2023
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Reiterates $1,300	Strong Buy	Reiterates	$1,300	+238,359.00%	Jan 12, 2023
Robert LeBoyer Noble Capital Markets	Noble Capital Markets	Buy Initiates $3,840	Buy	Initiates	$3,840	+704,357.90%	Apr 18, 2022
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $64 → $96	Strong Buy	Maintains	$64 → $96	+17,511.45%	Aug 31, 2021
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $128 → $64	Strong Buy	Maintains	$128 → $64	+11,640.96%	Aug 11, 2021
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $96 → $128	Strong Buy	Maintains	$96 → $128	+23,381.93%	Feb 25, 2021
Scott Henry Roth Capital	Roth Capital	Hold → Strong Buy Upgrades n/a	Hold → Strong Buy	Upgrades	n/a	n/a	Apr 18, 2019
Scott Henry Roth Capital	Roth Capital	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jul 27, 2018
Scott Henry Roth Capital	Roth Capital	Hold → Strong Buy Upgrades n/a	Hold → Strong Buy	Upgrades	n/a	n/a	Aug 18, 2017
Scott Henry Roth Capital	Roth Capital	Strong Buy Initiates $54,400,000	Strong Buy	Initiates	$54,400,000	+9,979,820,116.47%	Oct 1, 2013